JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5701
PUT
Dollar Tree
DLTR
$25.1B
| $32K | ﹤0.01% |
200
-60,000
| -100% | -$8.49M |
|
5702
Invesco AI and Next Gen Software ETF
IGPT
$1.2B
| $32K | ﹤0.01% |
858
| – | – |
|
5703
iShares Global Consumer Staples ETF
KXI
$1.07B
| $32K | ﹤0.01% |
518
-150
| -22% | -$9.35K |
|
5704
MidCap Financial Investment
MFIC
$801M
| $32K | ﹤0.01% |
2,400
-256,465
| -99% | -$3.4M |
|
5705
Nano X Imaging
NNOX
$73.7M
| $32K | ﹤0.01% |
2,965
| – | – |
|
5706
Pulse Biosciences
PLSE
$3.18B
| $32K | ﹤0.01% |
6,537
+1,181
| +22% | +$9.67K |
|
5707
Richardson Electronics
RELL
$301M
| $32K | ﹤0.01% |
2,553
+839
| +49% | +$10.5K |
|
|
TEF
5708
DELISTED
Telefonica
TEF
| $32K | ﹤0.01% |
6,927
-967
| -12% | -$4.31K |
|
5709
Aligos Therapeutics
ALGS
$42M
| $31K | ﹤0.01% |
587
+12
| +2% | +$961 |
|
5710
Biodesix
BDSX
$252M
| $31K | ﹤0.01% |
914
-1,548
| -63% | -$101K |
|
5711
CareCloud
CCLD
$105M
| $31K | ﹤0.01% |
5,965
+1,728
| +41% | +$9.47K |
|
5712
CSP Inc
CSPI
$79.1M
| $31K | ﹤0.01% |
8,000
+4,000
| +100% | +$16K |
|
5713
CVRx
CVRX
$83.9M
| $31K | ﹤0.01% |
5,206
-3,931
| -43% | -$31.7K |
|
5714
Data I/O
DAIO
$32.9M
| $31K | ﹤0.01% |
7,261
-3,205
| -31% | -$15K |
|
5715
Gabelli Equity Trust
GAB
$1.8B
| $31K | ﹤0.01% |
4,500
| – | – |
|
|
LYRA
5716
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $31K | ﹤0.01% |
155
+138
| +812% | +$30.3K |
|
5717
Roundhill Ball Metaverse ETF
METV
$214M
| $31K | ﹤0.01% |
2,569
+2,086
| +432% | +$26K |
|
5718
Rani Therapeutics
RANI
$89.9M
| $31K | ﹤0.01% |
2,329
-1,857
| -44% | -$30.8K |
|
5719
Spire Global
SPIR
$532M
| $31K | ﹤0.01% |
1,863
+211
| +13% | +$4.12K |
|
|
USAS
5720
Americas Gold and Silver
USAS
$1.76B
| $31K | ﹤0.01% |
11,620
-55,440
| -83% | -$132K |
|
5721
Value Line
VALU
$347M
| $31K | ﹤0.01% |
461
-1,014
| -69% | -$59.6K |
|
|
VINC
5722
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $31K | ﹤0.01% |
385
+72
| +23% | +$8.89K |
|
5723
Assembly Biosciences
ASMB
$628M
| $30K | ﹤0.01% |
1,232
+1,224
| +15,300% | +$26.3K |
|
5724
Aterian
ATER
$5.25M
| $30K | ﹤0.01% |
1,015
-3,289
| -76% | -$120K |
|
5725
BlackSky Technology
BKSY
$1.26B
| $30K | ﹤0.01% |
1,965
-1,586
| -45% | -$33.1K |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.